A drug for treating hepatitis B virus (HBV) could be mass-produced at a fraction of its current price - for only $36 (Rs.2,267) per person per year, versus the current US price of over $15,000 (Rs. 944,775), say researchers from University of Liverpool in Britain.
Liver cancer is life-threatening because it is generally diagnosed in the later stages. Now, scientists have identified a diagnostic biomarker of the disease and a potential way to reverse the damage done.
In an email interview with Salome Phelamei of Zee Media, Dr Suresh Singhvi, MBBS, MS, DNB, FRCS (Glasgow), FRCS (Intercollegiate, UK), CCST (UK), discussed in-depth about liver disease, transplantation, cost of treatment, preventions and many more.
Researchers from the Medical University of Vienna in Austria have discovered a new factor in the development and progression of the most common type of liver cancer, hepatocellular carcinoma (HCC), the university has said.
There could soon be a treatment for intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, as researchers have have now found how two genetic mutations in liver cells may drive tumour formation in iCCA.